NCT00824369 - A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

HIV-1

Interventions

DRUG

No drug will be administered

No drug will be administered.

Trial Locations (27)

3000

Pfizer Investigational Site, Dundee

6903

Pfizer Investigational Site, Lugano

7925

Pfizer Investigational Site, Cape Town

9007

Pfizer Investigational Site, Sankt Gallen

15586

Pfizer Investigational Site, Kota Bharu

20127

Pfizer Investigational Site, Milan

30308

Pfizer Investigational Site, Atlanta

33137

Pfizer Investigational Site, Miami

45267

Pfizer Investigational Site, Cincinnati

75235

Pfizer Investigational Site, Dallas

83045

Pfizer Investigational Site, Donetsk

95814

Pfizer Investigational Site, Sacramento

95817

Pfizer Investigational Site, Sacramento

C1405BCH

Pfizer Investigational Site, Buenos Aires

80240-280

Pfizer Investigational Site, Curitiba

26030-381

Pfizer Investigational Site, Nova Iguaçu

13015-080

Pfizer Investigational Site, Campinas

04121-000

Pfizer Investigational Site, São Paulo

01-201

Pfizer Investigational Site, Warsaw

1349-019

Pfizer Investigational Site, Lisbon

4200-319

Pfizer Investigational Site, Porto

00717-1563

Pfizer Investigational Site, Ponce

00909

Pfizer Investigational Site, Santurce

EH3 9HA

Pfizer Investigational Site, Edinburgh

EH4 2XU

Pfizer Investigational Site, Edinburgh

SW10 9NH

Pfizer Investigational Site, London

M8 5RB

Pfizer Investigational Site, Manchester